Matt Zemon, MSc’s Post

View profile for Matt Zemon, MSc, graphic

Educator, Author, and Leader in Psychedelic Wellness | Passionate Community Builder

Join the forefront of innovation! The University of North Carolina at Chapel Hill Department of Psychiatry, led by Dr.Robert McClure, is embarking on a groundbreaking journey and inviting you to participate in a pioneering clinical trial exploring the potential of psilocybin for treating Treatment-Resistant Depression (TRD). What is the study for?  This study seeks to answer critical questions: Can psilocybin, with assisted therapy, truly alleviate depression symptoms? How enduring are these effects? How Can You Get Involved?  If you or someone you know might benefit, take the first step by visiting the link below to learn more and apply! https://lnkd.in/gPx2QhSb What's in Store for Participants?  ✅ Screening and preparation visits ✅ Psilocybin treatment sessions ✅ Follow-up sessions over a year ✅ Surveys to track symptom changes and gather feedback Why It Matters? Depression weighs heavily on individuals worldwide, and current treatments often come up short. Psilocybin offers hope, but we need these trials to understand its full potential. This kind of research greatly enhances consumer trust and helps correct misconceptions about psychedelic medicines. For those of us involved in the ceremonial space, it offers scientific backing that helps connect traditional practices with widespread acceptance. This support enables us to promote and use these potent therapeutic tools more responsibly, fostering broader understanding and recognition of their significant benefits. Know someone who might be interested? Share this post, and let's make a difference together. Questions? Reach out to PilotPAT_study@med.unc.edu. #MentalHealth #MattZemon  #Psychedelics #PsilocybinResearch #UNCPsychiatry #MentalHealthMatters

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics